Cargando…

ZolpiMist™: a new formulation of zolpidem tartrate for the short-term treatment of insomnia in the US

ZolpiMist™ is an oral spray formulation of the hypnotic compound zolpidem that was approved by the US Food and Drug Administration in 2008 with an indication for the short-term treatment of insomnia characterized by difficulty with sleep initiation. It was developed by NovaDel Pharma, Inc. using the...

Descripción completa

Detalles Bibliográficos
Autor principal: Neubauer, David N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3630936/
https://www.ncbi.nlm.nih.gov/pubmed/23616700